41 studies found for:    Open Studies | "Carcinoma, Ductal, Breast"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Carcinoma, Ductal, Breast" (41 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Intensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients With Hormone Responsive Stage 0-I Breast Cancer
Conditions: Ductal Breast Carcinoma in Situ;   Estrogen Receptor-negative Breast Cancer;   Estrogen Receptor-positive Breast Cancer;   Invasive Ductal Breast Carcinoma;   Invasive Ductal Breast Carcinoma With Predominant Intraductal Component;   Lobular Breast Carcinoma in Situ;   Medullary Ductal Breast Carcinoma With Lymphocytic Infiltrate;   Mucinous Ductal Breast Carcinoma;   Papillary Ductal Breast Carcinoma;   Progesterone Receptor-positive Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Tubular Ductal Breast Carcinoma
Interventions: Radiation: accelerated partial breast irradiation;   Radiation: intensity-modulated radiation therapy;   Radiation: image-guided radiation therapy;   Procedure: therapeutic conventional surgery;   Other: questionnaire administration;   Other: laboratory biomarker analysis
2 Not yet recruiting Sentinel Lymph Node Identification in the Axilla of Women With Breast Cancer Using Ultrasound and Iron Injection
Conditions: Breast Neoplasm;   Carcinoma, Ductal, Breast;   Carcinoma, Intraductal, Noninfiltrating
Interventions: Procedure: Iron-tracer guided axillary ultrasound and biopsy;   Drug: Injection of iron-tracer
3 Recruiting Study of LOXO-101 in Subjects With NTRK Fusion Positive Solid Tumors
Conditions: Carcinoma, Non-Small-Cell Lung;   Thyroid Neoplasms;   Sarcoma;   Colorectal Neoplasms;   Salivary Gland Neoplasms;   Biliary Tract Neoplasms;   Brain Neoplasm, Primary;   Carcinoma, Ductal, Breast;   Melanoma;   Solid Tumors;   Glioblastoma;   Bile Duct Neoplasms;   Astrocytoma;   Head and Neck Squamous Cell Carcinoma;   Pontine Glioma
Intervention: Drug: LOXO-101
4 Not yet recruiting Evaluation of Percutaneous Treatment by Cryoablation of Unifocal Invasive Breast Carcinoma in Menopausal Women With Indication of Lumpectomy
Conditions: Carcinoma, Ductal, Breast;   Menopausal
Intervention: Device: Cryoablation
5 Recruiting Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer
Condition: Carcinoma, Ductal, Breast
Interventions: Procedure: Biopsy before and after three weeks of study treatment;   Drug: Paclitaxel;   Drug: lapatinib;   Drug: trastuzumab
6 Recruiting Broccoli Sprout Extract in Treating Patients With Breast Cancer
Conditions: Ductal Breast Carcinoma;   Ductal Breast Carcinoma In Situ;   Estrogen Receptor Negative;   Estrogen Receptor Positive;   Invasive Breast Carcinoma;   Lobular Breast Carcinoma;   Postmenopausal;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer
Interventions: Drug: Broccoli Sprout Extract;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Other: Placebo
7 Recruiting Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation Therapy
Conditions: Ductal Breast Carcinoma in Situ;   Invasive Ductal Breast Carcinoma;   Invasive Lobular Breast Carcinoma;   Lobular Breast Carcinoma in Situ;   Recurrent Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer
Interventions: Behavioral: Behavioral dietary intervention;   Procedure: Therapeutic conventional surgery;   Radiation: Radiation therapy;   Other: Counseling intervention;   Procedure: Quality-of-life assessment
8 Recruiting Targeted Intraoperative Radiotherapy United States (TARGIT-US) Registry Trial
Conditions: Malignant Neoplasm of Breast;   Breast Diseases;   Ductal Breast Carcinoma
Intervention: Radiation: Intraoperative radiation therapy (IORT)
9 Recruiting Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive Breast Cancer Patients
Conditions: Tubular Breast Cancer;   Mucinous Breast Cancer;   Invasive Ductal Breast Cancer;   Inflammatory Breast Cancer
Interventions: Drug: Paclitaxel;   Drug: Cisplatin;   Drug: Gonadotropin-releasing hormone agonist;   Drug: Letrozole
10 Recruiting Addition of Cisplatin to Neoadjuvant Therapy for T Locally Advanced Breast Cancer
Conditions: Tubular Breast Cancer;   Mucinous Breast Cancer;   Invasive Ductal Breast Cancer;   Inflammatory Breast Cancer
Interventions: Drug: Paclitaxel;   Drug: Cisplatin
11 Recruiting A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)
Conditions: Tubular Breast Cancer Stage II;   Tubular Breast Cancer Stage III;   Mucinous Breast Cancer Stage II;   Breast Cancer Female NOS;   Invasive Ductal Breast Cancer;   HER2 Positive Breast Cancer;   Inflammatory Breast Cancer
Interventions: Drug: non-pegylated liposomal doxorubicin;   Drug: Carboplatin;   Drug: Paclitaxel;   Drug: Epirubicin;   Drug: Cyclophosphamide;   Drug: Pertuzumab;   Drug: Trastuzumab;   Drug: Ferric carboxymaltose
12 Recruiting Lumpectomy Followed By Intraoperative Electron Radiation Therapy (IOERT)
Conditions: Invasive Ductal Breast Cancer;   Carcinoma Breast Stage I
Intervention: Radiation: Intraoperative Electron Radiotherapy
13 Not yet recruiting Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer
Condition: Ductal Breast Carcinoma In Situ
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Nelipepimut-S Plus GM-CSF Vaccine;   Biological: Sargramostim
14 Recruiting Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After Surgery
Conditions: Ductal Breast Carcinoma In Situ;   Estrogen Receptor Positive;   Invasive Breast Carcinoma;   Progesterone Receptor Positive;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer
Interventions: Radiation: Accelerated Partial Breast Irradiation;   Radiation: High-Dose Rate Brachytherapy;   Other: Laboratory Biomarker Analysis;   Other: Questionnaire Administration
15 Recruiting Effects of Chemotherapy on Intestinal Bacteria in Patients With Newly Diagnosed Breast Cancer
Conditions: Ductal Breast Carcinoma In Situ;   Invasive Breast Carcinoma;   Stage I Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIA Breast Cancer
Interventions: Other: Cytology Specimen Collection Procedure;   Other: Laboratory Biomarker Analysis;   Other: Questionnaire Administration
16 Recruiting MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Condition: Ductal Breast Carcinoma In Situ
Interventions: Procedure: Magnetic Resonance Imaging;   Procedure: Therapeutic Conventional Surgery;   Procedure: Therapeutic Surgical Procedure;   Radiation: Radiation Therapy;   Drug: Endocrine Therapy;   Other: Quality-of-Life Assessment;   Other: Laboratory Biomarker Analysis;   Other: Cytology Specimen Collection Procedure
17 Not yet recruiting Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy
Conditions: BRCA1 Mutation Carrier;   BRCA2 Mutation Carrier;   Ductal Breast Carcinoma In Situ;   Lobular Breast Carcinoma In Situ;   Stage 0 Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer
Interventions: Drug: Telapristone Acetate;   Other: Placebo;   Other: Laboratory Biomarker Analysis;   Other: Questionnaire Administration
18 Recruiting Pilot Study of Curcumin for Women With Obesity and High Risk for Breast Cancer
Conditions: Atypical Ductal Breast Hyperplasia;   BRCA1 Gene Mutation;   BRCA2 Gene Mutation;   Ductal Breast Carcinoma in Situ;   Lobular Breast Carcinoma in Situ
Interventions: Dietary Supplement: curcumin;   Other: Biomarker analysis;   Other: Assessment of Dietary Intake;   Other: Daily Log
19 Recruiting Metformin Hydrochloride in Patients With Atypical Hyperplasia or In Situ Breast Cancer to Placebo in Decreasing Atypical Cells in Patients With Atypical Hyperplasia or in Situ Breast Cancer
Conditions: Atypical Ductal Breast Hyperplasia;   BRCA1 Mutation Carrier;   BRCA2 Mutation Carrier;   Ductal Breast Carcinoma in Situ;   Lobular Breast Carcinoma in Situ
Interventions: Drug: metformin hydrochloride;   Other: placebo
20 Recruiting Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer
Conditions: Ductal Breast Carcinoma in Situ;   Lobular Breast Carcinoma in Situ;   Male Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Dietary Supplement: omega-3 fatty acid;   Other: placebo;   Other: laboratory biomarker analysis

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years